Legal Opinion of Beijing Guofeng Law Firm on the 2023 Restricted Stock Incentive Plan of Beijing Kangchen Pharmaceutical Co., Ltd. to repurchase and cancel some restricted shares

SZSI · Sep 30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.